A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

DAWn Consortium Members

Research output: Contribution to journal › A1: Web of Science-article › peer-review

17 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study'. Together they form a unique fingerprint.

Medicine & Life Sciences